Common Transcriptomic Effects of Abatacept and Other DMARDs on Rheumatoid Arthritis Synovial Tissue

OBJECTIVES: Our goal was to assess for the histological and transcriptomic effects of abatacept on RA synovia, and to compare them with previously published data from four other DMARDs: tocilizumab, rituximab, methotrexate, and adalimumab. METHODS: Synovial tissue was obtained using ultrasound-guide...

Descripción completa

Detalles Bibliográficos
Autores principales: Triaille, Clement, Durez, Patrick, Sokolova, Tatiana, Tilman, Gaëlle, Méric de Bellefon, Laurent, Galant, Christine, Coulie, Pierre, Lauwerys, Bernard R., Limaye, Nisha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435834/
https://www.ncbi.nlm.nih.gov/pubmed/34526997
http://dx.doi.org/10.3389/fimmu.2021.724895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435834/
https://www.ncbi.nlm.nih.gov/pubmed/34526997
http://dx.doi.org/10.3389/fimmu.2021.724895

Ejemplares similares